Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus in Active Rheumatoid Arthritis Resistant to Methotrexate
NCT01224041Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2009
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus + Wuzhi capsule in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Primary endpoint: American College of Rheumatology 20% Response at 6 months. Started Aug 2009; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01224041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224041.